Included in this section:|
Alcohol-Induced Liver Decompensation Study: This is a study to assess safety and efficacy of ELADŽ in subjects with alcohol- induced liver decompensation (AILD)
Assessment of Long Term Outcomes on Entecavir: A study on the observational assessment of long-term outcomes on Entecavir
Hepatitis C Treatment in Patients Also Diagnosed With Hemophilia: This is a study of an investigational drug in the treatment of hepatitis C in patients also diagnosed with hemophilia
Liver & Kidney Transplant Trial: This study will examine the effectiveness of changing immunosuppresive drugs in patients who have had a kidney or liver transplant within the past six months and have developed abnormal glucose levels.
Severe Liver Disease and Accompanying Hepatic Encephalopathy: This is a study testing the safety and effectiveness of an FDA approved drug, rifaximin, in patients with severe liver disease and accompanying hepatic encephalopathy.
Treatment of Mild Hepatic Encephalopathy Study: The purpose of this study is to obtain information on the safety and the effectiveness of an experimental drug compared to placebo when it is used to treat mild encephalopathy.